EG ·
CRYPTONAZ 100 MG / 5 ML 60 ML SUSP
CRYPTONAZ 100 MG / 5 ML 60 ML SUSP
Composition
These source-reported data require scientific review and are not treatment advice.
NITAZOXANIDE
· AMOUNT_PER_UNIT
NITAZOXANIDE
· AMOUNT_PER_UNIT
Registration
Packages and prices
CRYPTONAZ 100 MG / 5 ML 60 ML SUSPENSION
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| NITAZODE 100MG/5ML 60ML SUSP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| NANAZOXID 500MG 18 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| CRYPTONAZ 500MG 12/TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| antidiazox 500 mg 6 tab | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| EGYGASTREAZ 500 MG 20 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| nanazoxid 500MG tab | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| antidiazox 500 mg 12 tab | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| CRYPTOSEPT 500 MG 12 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |
| XEROVIRINC 500 MG 18 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |
| Nanazoxide 100MG 60ml susp | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| PROTOSTOP 500 MG 6 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |
| EGYGASTREAZ 50 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |